Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer

PURPOSE: Immune checkpoint inhibitors (ICIs) have recently emerged as an important option for treating patients with advanced non-small cell lung cancer (NSCLC). Neoantigens are important biomarkers and potential immunotherapy targets that play important roles in the prognosis and treatment of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Hongge, Xu, Yan, Chen, Minjiang, Zhao, Jing, Zhong, Wei, Liu, Xiaoyan, Gao, Xiaoxing, Li, Shanqing, Li, Ji, Guo, Chao, Jia, He, Wang, Mengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959482/
https://www.ncbi.nlm.nih.gov/pubmed/35356154
http://dx.doi.org/10.3389/fimmu.2021.749461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959482/
https://www.ncbi.nlm.nih.gov/pubmed/35356154
http://dx.doi.org/10.3389/fimmu.2021.749461

Ejemplares similares